The UK government has announced new changes to the national electricity markets with the hopes of creating a system that is fairer, more secure, and affordable for working families and businesses.
New clinical trial data shows that the Johnson & Johnson vaccine is able to give 66% protection against COVID in one dose - with an 85% efficiency at the standard double-dose.
Phase Three data from the UK trial shows that Novavax still works powerfully against the UK mutation, with a less intense impact on the South African mutation at 60%.
New data from the REACT study finds that the rising infection rate has steadied a little, but there is no "sharp drop in infections" as in the first wave and the R is still high.
Prime Minister Boris Johnson announced that he had done "everything possible" to prevent 100,000 COVID deaths, as the UK witnesses 50,099 fatalities in the space of 79 days.
Tomorrow (26 January) the COVID 'O' meeting is expected to be a moment of decision-making about border policy, as the more infectious South African and Brazilian COVID mutations continue to circulate.
Data from Queen Mary University of London suggests that Asian COVID patients are 1.5 times as likely to die as white patients - with Black patients 1.3 times more likely to die.
Paul Bensley, Managing Director at X-on, discusses how patient communications could be the only way to solve complex logistical considerations for mass vaccination.
Professor Herb Sewell, expert in immunology, wrote that the UK Government should not rely on one dose of the vaccine - suggesting that the diluted vaccine could encourage mutations to evolve.
New data from the REACT study says that there have been more than 20 hospitals' worth of new patients since Christmas Eve, putting "extreme pressure" on the NHS.
After a year of unprecedented politics, a new APPG on Political Literacy has launched - from Brexit to Black Lives Matter, young people appear to be highly politically engaged without any formal support in schools.
The UK Government has outlined guidance for those concerned about paying utility bills or repaying credit cards, loans or mortgages due to the impact of coronavirus.
An initial £2.5 million will launch the 'G2P-UK' National Virology Consortium, which will investigate COVID-19 mutations to figure out how they impact vaccines.
